Follow
Timea Varadi
Timea Varadi
Other namesTímea Váradi
Austrian Tribology Society
Verified email at oetg.at - Homepage
Title
Cited by
Cited by
Year
Comparative analysis of fluorescence resonance energy transfer (FRET) and proximity ligation assay (PLA)
MM Mocanu, T Váradi, J Szöllősi, P Nagy
Proteomics 11 (10), 2063-2070, 2011
482011
The dipole potential modifies the clustering and ligand binding affinity of ErbB proteins and their signaling efficiency
T Kovács, G Batta, T Hajdu, Á Szabó, T Váradi, F Zákány, I Csomós, ...
Scientific reports 6 (1), 35850, 2016
272016
Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan
T Váradi, T Mersich, P Auvinen, R Tammi, M Tammi, F Salamon, ...
Journal of Histochemistry & Cytochemistry 60 (8), 567-575, 2012
232012
ErbB protein modifications are secondary to severe cell membrane alterations induced by elisidepsin treatment
T Váradi, J Roszik, D Lisboa, G Vereb, JM Molina-Guijarro, CM Galmarini, ...
European journal of pharmacology 667 (1-3), 91-99, 2011
212011
Maximum likelihood estimation of FRET efficiency and its implications for distortions in pixelwise calculation of FRET in microscopy
P Nagy, Á Szabó, T Váradi, T Kovács, G Batta, J Szöllősi
Cytometry Part A 85 (11), 942-952, 2014
202014
Epigallocatechin 3-O-gallate Induces 67 kDa Laminin Receptor-Mediated Cell Death Accompanied by Downregulation of ErbB Proteins and Altered Lipid Raft …
MM Mocanu, C Ganea, L Georgescu, T Varadi, D Shrestha, I Baran, ...
Journal of Natural Products 77 (2), 250-257, 2014
202014
rFRET: A comprehensive, Matlab‐based program for analyzing intensity‐based ratiometric microscopic FRET experiments
P Nagy, Á Szabó, T Váradi, T Kovács, G Batta, J Szöllősi
Cytometry Part A 89 (4), 376-384, 2016
192016
Homo-and heteroassociations drive activation of ErbB3
T Váradi, M Schneider, E Sevcsik, D Kiesenhofer, F Baumgart, G Batta, ...
Biophysical journal 117 (10), 1935-1947, 2019
162019
Comprehensive model for epidermal growth factor receptor ligand binding involving conformational states of the extracellular and the kinase domains
T Hajdu, T Váradi, I Rebenku, T Kovács, J Szöllösi, P Nagy
Frontiers in Cell and Developmental Biology 8, 776, 2020
152020
Hypoxia reduces the efficiency of elisidepsin by inhibiting hydroxylation and altering the structure of lipid rafts
A Király, T Váradi, T Hajdu, R Rühl, CM Galmarini, J Szöllősi, P Nagy
Marine Drugs 11 (12), 4858-4875, 2013
102013
Preliminary investigations for the application of composite electrodes in organic electrosynthesis
D Szikra, T Varadi, IP Nagy
Journal of New Materials for Electrochemical Systems 11, 273-279, 2008
32008
5027 POSTER binding of trastuzumab to ErbB2 is inhibited by a high local density of hyaluronan
T Varadi, MM Mocanu, T Mersich, P Auvinen, R Tammi, M Tammi, ...
European Journal of Cancer, S339, 2011
12011
Critical analysis of in vitro stability testing of spinal implants and proposal for standardization
Z Csernátony, S Manó, Z Tiba, G Husi, Z Jónás, T Váradi, L Csámer, ...
Expert Review of Medical Devices 19 (3), 281-286, 2022
2022
Maximum Likelihood Estimation of FRET Efficiency
P Nagy, A Szabo, T Varadi, T Kovacs, G Batta, T Szatmari, J Szollosi
Biophysical Journal 106 (2), 204a, 2014
2014
C-erbB3 protein modifications are secondary to severe cell membrane alterations induced by Irvalec treatment in CHO cells
T Váradi, JMM Guijarro, G Vereb, CM Galmarini, J Szöllõsi, P Nagy
Cancer Research 70 (8_Supplement), 4464-4464, 2010
2010
Receptor-orientált daganatterápia vizsgálata ErbB fehérjéket kifejező humán tumorokban
VT Erzsébet
204a Sunday, February 16, 2014
P Nagy, A Szabo, T Varadi, T Kovacs, G Batta, T Szatmari, J Szollosi
The system can't perform the operation now. Try again later.
Articles 1–17